Skip to main content
Premium Trial:

Request an Annual Quote

ABI, Celera Look to Sell Some California Real Estate

NEW YORK (GenomeWeb News) – Celera Genomics and Applied Biosystems are looking to sell some California real estate.
Celera Genomics is seeking to sell a 44,000-square-foot facility in South San Francisco that had been used for its scuttled small-molecule drug-discovery efforts, the company said in a Securities and Exchange Commission filing yesterday.
The facility sits on land parent Applera leases under a long-term ground lease, the company said. This space, together with three leased facilities totaling 108,000 square feet, was part of Celera’s small-molecule drug-discovery and –development business.
As of the end of June, Celera discontinued all internal research and development efforts in these programs and had vacated “substantially all” of the space in these facilities. Two of the leases expired in August and one will run out in December.
Meantime ABI is looking to lease “several” facilities in an undisclosed city, and to sell a 15-acre plot of land it owns in Vacaville, the company said in the SEC filing.
ABI has also finished constructing the shell of a building that sits on an 80-acre parcel it owns in Pleasanton. This space is around 164,000 square feet and ABI said it “intends” to make improvements to the space as needed for itself or “possibly the operations of our other businesses.”
ABI also said it may build additional R&D, manufacturing, administrative, or “other facilities” on this land, up to a maximum of approximately 700,000 additional square feet, “as may be required for the future growth of our businesses.”

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.